| Kerri Claussen Odhner, DMD, MS | |
|
960 Old York Rd Ste 101, Abington, PA 19001-4709 | |
| (215) 887-0376 | |
| Not Available |
| Full Name | Kerri Claussen Odhner |
|---|---|
| Gender | Female |
| Speciality | Dentist - Orthodontics And Dentofacial Orthopedics |
| Location | 960 Old York Rd Ste 101, Abington, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528475589 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223X0400X | Dentist - Orthodontics And Dentofacial Orthopedics | DS039171 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kerri Claussen Odhner, DMD, MS 960 Old York Rd Ste 101, Abington, PA 19001-4709 Ph: () - | Kerri Claussen Odhner, DMD, MS 960 Old York Rd Ste 101, Abington, PA 19001-4709 Ph: (215) 887-0376 |
News Archive
One-third of children with a microdeletion of chromosome 22 will later develop a psychotic illness such as schizophrenia. But how do we know which of these children might be affected? Today, various studies have contributed to the understanding of the neurobiological mechanisms that are associated with the development of psychotic illnesses.
Using a "chemical nose" array of nanoparticles and polymers, researchers at the University of Massachusetts Amherst have developed a fundamentally new, more effective way to differentiate not only between healthy and cancerous cells but also between metastatic and nonmetastatic cancer cells. It is a tool that could revolutionize cancer detection and treatment, according to Vincent M. Rotello, Ph.D., M.Phil., and D. Joseph Jerry, Ph.D., M.S., the investigators who led the study.
Members of the Consolidated Research Group of Molecular Neurobiology of the Department of Biochemistry and Molecular Biology of the University of Barcelona (UB), affiliated with the Centre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), have published a study in the journal Proceedings of the National Academy of Sciences (PNAS) about the formation of G protein-coupled receptors (GPCRs) which allows understanding the unexpected behaviour of some antagonists that block physiological responses.
Allos Therapeutics, Inc. today announced the pricing of an underwritten public offering of 14,000,000 primary shares of its common stock at a public offering price of $7.10 per share.
› Verified 4 days ago
Ashley Page Mcdowell, DMD Dentist Medicare: Medicare Enrolled Practice Location: 1047 Old York Rd, Abington, PA 19001 Phone: 215-885-0555 Fax: 215-885-2075 | |
Hadi Ghazzouli, DMD Dentist Medicare: Medicare Enrolled Practice Location: 1377 Old York Rd, Abington, PA 19001 Phone: 215-884-3032 | |
Mrs. Mona N. Patel, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1919 Susquehanna Road, Abington, PA 19001 Phone: 215-884-3477 Fax: 215-884-6638 | |
Alon Bekerman, Dentist Medicare: Not Enrolled in Medicare Practice Location: 1021 Old York Rd Ste 201, Abington, PA 19001 Phone: 215-886-4203 Fax: 215-886-4201 | |
Dr. Lance Lorch, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1904 Old York Rd, Abington, PA 19001 Phone: 215-659-6313 | |
Dr. Stephen Jay Finkelman, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1755 Old York Rd, Abington, PA 19001 Phone: 215-659-0337 Fax: 215-659-9419 | |
Dr. Robert Machlus, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 1755 Old York Rd, Abington, PA 19001 Phone: 215-659-0337 |